Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03117803
Other study ID # 2016YFC1300801
Secondary ID
Status Recruiting
Phase N/A
First received April 4, 2017
Last updated July 2, 2017
Start date May 1, 2017
Est. completion date December 30, 2021

Study information

Verified date April 2017
Source Tang-Du Hospital
Contact Wei Guo, M.D, Ph.D
Phone 86-18729985168
Email 18729985168@163.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This is a registry study of the natural course of unruptured intracranial aneurysms (UIA). In addition, the investigators will analyze the risk factors for the rupture of the UIA and their joint effect. The investigators aim to use research data to create a China national database of UIA.


Description:

This is a registry study of the natural course of unruptured intracranial aneurysms (UIA). In addition, the investigators will analyze the risk factors for the rupture of the UIA and their joint effect. The investigators aim to use research data to create a China national database of UIA.

This study is supported by a research grant from the Ministry of Science and Technology of the People's Republic of China. The investigators will collaborate with the other 19 medical centers which locate in the different districts of China. During the study period, all the patients included in this study will observe and treat in the collaborating medical centers. Included patients will be followed-up for at least 1year.

Research data will represent the real natural course of UIA in China.

For this study, the investigators consulted and hired professional experts about data collection, data and methodology. An intact systematic project steering committee, including Data Monitoring Committee, Data Management Committee, Project Academic Committee, Executive Group, Project Manager, Project Statistician, and Technical Support Center has been built up. Scientific regulations have also been made.


Recruitment information / eligibility

Status Recruiting
Enrollment 5000
Est. completion date December 30, 2021
Est. primary completion date December 30, 2020
Accepts healthy volunteers No
Gender All
Age group 14 Years and older
Eligibility Inclusion Criteria:

1. Diagnosis of untreated unruptured intracranial aneurysm (by CTA, MRA or DSA)

2. Patient with premorbid mRS of 3 or less.

3. Patient older than 18 years

4. Patient consenting to participate to the study

Exclusion Criteria:

1. Subarachnoid hemorrhage with unknown causes

2. Patient with other cerebral arteriovenous malformations or cerebral arteriovenous fistulas

3. Patient with malignant tumor

4. Target aneurysm is fusiform, traumatic, mycotic, or dissecting related.

5. Inability to obtain informed consent.

6. Patients with a life expectancy less than 1 year

7. Participating in the other clinical studies of intracranial aneurysm

8. Refusal of follow-up

Study Design


Locations

Country Name City State
China Tandu Hospital, Fourth Military Medical University Xi'an Shaanxi

Sponsors (2)

Lead Sponsor Collaborator
Tang-Du Hospital Xuanwu Hospital, Beijing

Country where clinical trial is conducted

China, 

References & Publications (3)

International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms--risk of rupture and risks of surgical intervention. N Engl J Med. 1998 Dec 10;339(24):1725-33. Erratum in: N Engl J Med 1999 Mar 4;340(9):744. — View Citation

UCAS Japan Investigators, Morita A, Kirino T, Hashi K, Aoki N, Fukuhara S, Hashimoto N, Nakayama T, Sakai M, Teramoto A, Tominari S, Yoshimoto T. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012 Jun 28;366(26):2474-82. doi: 10.1056/NEJMoa1113260. — View Citation

Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, Piepgras DG, Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003 Jul 12;362(9378):103-10. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary aneurysm rupture rate aneurysm rupture rate Up to 4 years or time of aneurysm repair surgery
Secondary Morphological changes of aneurysms maximum diameter increase = 1mm or appearance of a daughter sac Up to 4 years or time of aneurysm repair surgery
See also
  Status Clinical Trial Phase
Terminated NCT05544045 - China Surpass Streamline Post-Market Study
Not yet recruiting NCT02820779 - New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry N/A
Active, not recruiting NCT04195568 - Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System N/A
Withdrawn NCT04886505 - An EFS Assessing the Electrolytic eCLIPs System for Treatment of Intracranial Aneurysms N/A
Recruiting NCT05029947 - Setting Benchmarks for Microsurgical Clipping of Unruptured Intracranial Aneurysms
Recruiting NCT04852783 - US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair Phase 4
Completed NCT02354300 - Transcranial Doppler Ultrasound Monitoring During Flow-Diverter Embolization N/A